Ingalls & Snyder LLC cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 16.2% during the second quarter, HoldingsChannel reports. The firm owned 12,688 shares of the pharmacy operator’s stock after selling 2,450 shares during the period. Ingalls & Snyder LLC’s holdings in Walgreens Boots Alliance were worth $761,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in WBA. Archford Capital Strategies LLC acquired a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $115,000. Alpha Omega Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 100.0% in the first quarter. Alpha Omega Wealth Management LLC now owns 1,600 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 800 shares in the last quarter. Squar Milner Financial Services LLC acquired a new stake in Walgreens Boots Alliance in the second quarter valued at approximately $106,000. Kaizen Advisory LLC boosted its stake in Walgreens Boots Alliance by 128.6% in the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after acquiring an additional 1,083 shares in the last quarter. Finally, QCI Asset Management Inc. NY boosted its stake in Walgreens Boots Alliance by 95.9% in the first quarter. QCI Asset Management Inc. NY now owns 2,155 shares of the pharmacy operator’s stock valued at $141,000 after acquiring an additional 1,055 shares in the last quarter. Hedge funds and other institutional investors own 61.99% of the company’s stock.

NASDAQ WBA opened at $67.80 on Friday. The firm has a market capitalization of $68.75 billion, a price-to-earnings ratio of 13.29, a P/E/G ratio of 1.14 and a beta of 1.10. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.89. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.47 by $0.06. The business had revenue of $34.33 billion during the quarter, compared to analysts’ expectations of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The business’s quarterly revenue was up 14.0% on a year-over-year basis. During the same quarter last year, the company posted $1.33 earnings per share. equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.97 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 12th. Shareholders of record on Monday, August 20th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Friday, August 17th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.60%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 34.51%.

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, August 2nd. The shares were sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now owns 10,943 shares of the company’s stock, valued at $722,128.57. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Stefano Pessina bought 1,697,438 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, July 16th. The shares were acquired at an average cost of $63.92 per share, with a total value of $108,500,236.96. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

Several equities research analysts have weighed in on WBA shares. ValuEngine downgraded shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Tuesday, May 22nd. Loop Capital raised their target price on shares of Walgreens Boots Alliance to $80.00 and gave the company a “buy” rating in a research note on Friday, June 29th. Citigroup downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “neutral” rating and set a $69.00 target price for the company. in a research note on Monday, July 9th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Saturday, June 16th. Finally, Royal Bank of Canada restated an “outperform” rating on shares of Walgreens Boots Alliance in a research note on Friday, June 29th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $77.22.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Further Reading: Short Selling

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.